{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:13Z","timestamp":1792791493849,"version":"4.5.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260692-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>\n                      According to the Neonatal Oxygenation Prospective Meta-Analysis, a higher oxygen saturation as measured by pulse oximetry (Sp\n                      <jats:sc>o<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      ) target range, compared with a lower Sp\n                      <jats:sc>o<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      target, may reduce mortality but increase the risk of treated retinopathy of prematurity (ROP). Choosing a target range at an individual center may depend on the local baseline risks and the value placed on prioritizing survival over the risk of severe retinopathy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260692-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To estimate trade-offs between mortality and treated ROP associated with Sp\n                      <jats:sc>o<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      targeting and the association between variation in baseline risks and these trade-offs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260692-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This decision analytical modeling study used US national birth data and the Vermont Oxford Network database (2019-2023), incorporating gestational age (GA) and 16 performance subgroups (based on quartiles of center-specific mortality and retinopathy risks), to simulate an annual birth cohort of infants born extremely preterm (GA 23-27 weeks). The data were analyzed between January and August 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260692-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>\n                      High Sp\n                      <jats:sc>o<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      (91%-95%) vs low Sp\n                      <jats:sc>o<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      (85%-89%) target ranges.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260692-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>\n                      The primary outcome was the risk trade-off ratio (RTOR) of additional cases of treated ROP per death averted. Estimates of outcomes comparing universal adoption of the high or low Sp\n                      <jats:sc>o<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      targets were summarized using results of a probabilistic sensitivity analysis. Scenarios were also included that incorporated selective adoption of high or low targets based on performance quartiles.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260692-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 19\u202f050 simulated infants (2372 [12.5%] born at GA 23 weeks, 3253 [17.1%] at GA 24 weeks, 3809 [20.0%] at GA 25 weeks, 4357 [22.9%] at GA 26 weeks, and 5259 [27.6%] at GA 27 weeks), which approximated the distribution of extremely preterm births in the US, universal adoption of the higher Sp\n                      <jats:sc>o<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      target range was associated with a mean of 638 fewer deaths (95% uncertainty interval [UI], \u2212363 to \u2212934 deaths) and a mean of 551 additional cases (95% UI, 435-659 additional cases) of treated ROP. The mean RTOR with the high Sp\n                      <jats:sc>o<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      target range was 0.91 (95% UI, 0.61-1.43). Across performance subgroups, RTORs were 0.16 (95% UI, 0.00-0.40) in centers with the highest risk of mortality (4th quartile) and lowest risk of treated ROP (1st quartile) and 2.52 (95% UI, 1.39-4.72) for centers with the highest mortality (1st quartile) and lowest risk of treated ROP (4th quartile). Selective adoption of target ranges was favored in 50% of simulations if 2 cases of treated retinopathy per death averted were considered acceptable. Universal adoption of the high target range was favored in more than 90% of simulations if 4 or more cases of treated ROP were acceptable for each death averted.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260692-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>\n                      This decision analytical modeling study of a US cohort of extremely preterm infants found that the RTOR for treated ROP and mortality during Sp\n                      <jats:sc>o<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      targeting varied by GA and local baseline risks. This decision analysis may help inform the choice of Sp\n                      <jats:sc>o<\/jats:sc>\n                      <jats:sub>2<\/jats:sub>\n                      target ranges in individual clinical centers.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.24727","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:00:34Z","timestamp":1784646034000},"page":"e2624727","source":"Crossref","is-referenced-by-count":1,"title":["Modeling Oxygen Saturation Targets, Mortality, and Retinopathy Among Extremely Preterm Infants"],"prefix":"10.1001","volume":"9","author":[{"given":"Brian C.","family":"King","sequence":"first","affiliation":[{"name":"Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Division of Newborn Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A. F.","family":"Zupancic","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Division of Newborn Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika M.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Vermont Oxford Network, Burlington"},{"name":"Department of Pediatrics, Robert Larner College of Medicine, University of Vermont, Burlington"},{"name":"Department of Mathematics and Statistics, College of Engineering and Mathematical Sciences, University of Vermont, Burlington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle E. Y.","family":"Ehret","sequence":"additional","affiliation":[{"name":"Vermont Oxford Network, Burlington"},{"name":"Department of Pediatrics, Robert Larner College of Medicine, University of Vermont, Burlington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Horbar","sequence":"additional","affiliation":[{"name":"Vermont Oxford Network, Burlington"},{"name":"Department of Pediatrics, Robert Larner College of Medicine, University of Vermont, Burlington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger F.","family":"Soll","sequence":"additional","affiliation":[{"name":"Vermont Oxford Network, Burlington"},{"name":"Department of Pediatrics, Robert Larner College of Medicine, University of Vermont, Burlington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara K.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"4","key":"zoi260692r1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011190.pub2","article-title":"Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants.","volume":"4","author":"Askie","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"21","key":"zoi260692r2","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1001\/jama.2018.5725","article-title":"Association between oxygen saturation targeting and death or disability in extremely preterm infants in the neonatal oxygenation prospective meta-analysis collaboration.","volume":"319","author":"Askie","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"zoi260692r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2020.101080","article-title":"Oxygen saturation target ranges and alarm settings in the NICU: what have we learnt from the Neonatal Oxygenation Prospective Meta-Analysis (NeOProM)?","volume":"25","author":"Schmidt","year":"2020","journal-title":"Semin Fetal Neonatal Med"},{"issue":"2","key":"zoi260692r4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-1576","article-title":"Oxygen targeting in extremely low birth weight infants.","volume":"138","author":"Cummings","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"zoi260692r5","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2016.4396","article-title":"Variation in performance of neonatal intensive care units in the United States.","volume":"171","author":"Horbar","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"1","key":"zoi260692r6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1524-4733.2003.00234.x","article-title":"Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices\u2013Modeling Studies.","volume":"6","author":"Weinstein","year":"2003","journal-title":"Value Health"},{"issue":"1","key":"zoi260692r7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"issue":"3","key":"zoi260692r8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1001\/jama.2021.23580","article-title":"Mortality, in-hospital morbidity, care practices, and 2-year outcomes for extremely preterm infants in the US, 2013-2018.","volume":"327","author":"Bell","year":"2022","journal-title":"JAMA"},{"issue":"26","key":"zoi260692r10","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1056\/NEJM198806303182605","article-title":"An assessment of clinically useful measures of the consequences of treatment.","volume":"318","author":"Laupacis","year":"1988","journal-title":"N Engl J Med"},{"issue":"7168","key":"zoi260692r11","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/bmj.317.7168.1309","article-title":"Confidence intervals for the number needed to treat.","volume":"317","author":"Altman","year":"1998","journal-title":"BMJ"},{"key":"zoi260692r12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ajo.2022.08.010","article-title":"Association between retinopathy of prematurity in very-low-birth-weight infants and neurodevelopmental impairment.","volume":"244","author":"Han","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"zoi260692r13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/jamaophthalmol.2016.0391","article-title":"Ophthalmologic outcome of extremely preterm infants at 6.5 years of age: Extremely Preterm Infants in Sweden Study (EXPRESS).","volume":"134","author":"Hellgren","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"zoi260692r14","doi-asserted-by":"publisher","first-page":"F532","DOI":"10.1136\/archdischild-2016-312533","article-title":"Severe retinopathy of prematurity predicts delayed white matter maturation and poorer neurodevelopment.","volume":"102","author":"Glass","year":"2017","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"5","key":"zoi260692r15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1001\/jama.2013.282153","article-title":"Association between severe retinopathy of prematurity and nonvisual disabilities at age 5 years.","volume":"311","author":"Schmidt","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"zoi260692r16","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1159\/000538907","article-title":"ROP: 80 years after its detection \u2013 where do we stand and how long will we continue to laser?","volume":"121","author":"Hellstr\u00f6m","year":"2024","journal-title":"Neonatology"},{"issue":"1","key":"zoi260692r17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40273-022-01201-2","article-title":"Health-related quality-of-life outcomes of very preterm or very low birth weight adults: evidence from an individual patient data meta-analysis.","volume":"41","author":"Bolbocean","year":"2023","journal-title":"Pharmacoeconomics"},{"key":"zoi260692r18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jpeds.2016.08.018","article-title":"Health-related quality of life trajectories of extremely low birth weight survivors into adulthood.","volume":"179","author":"Saigal","year":"2016","journal-title":"J Pediatr"},{"issue":"1","key":"zoi260692r19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jval.2011.08.002","article-title":"A review of generic preference-based measures of health-related quality of life in visual disorders.","volume":"15","author":"Tosh","year":"2012","journal-title":"Value Health"},{"issue":"11","key":"zoi260692r20","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/archopht.122.11.1659","article-title":"Health-related quality of life at age 10 years in very low-birth-weight children with and without threshold retinopathy of prematurity.","volume":"122","author":"Quinn","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"zoi260692r21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/0272989X17732990","article-title":"A systematic review and meta-analysis of childhood health utilities.","volume":"38","author":"Kwon","year":"2018","journal-title":"Med Decis Making"},{"issue":"1","key":"zoi260692r23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12955-021-01677-0","article-title":"A comparison of self-reported and proxy-reported health utilities in children: a systematic review and meta-analysis.","volume":"19","author":"Jiang","year":"2021","journal-title":"Health Qual Life Outcomes"},{"issue":"10258","key":"zoi260692r24","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"zoi260692r25","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1055\/s-0044-1780523","article-title":"Variability in practice and implementation of oxygen target saturation policies in United States\u2019 neonatal intensive care units.","volume":"41","author":"Parikh","year":"2024","journal-title":"Am J Perinatol"},{"issue":"1","key":"zoi260692r26","first-page":"106","article-title":"Intermediate vs. high oxygen saturation targets in preterm infants: a national cohort study.","volume":"122","author":"Taylor","year":"2025","journal-title":"Neonatology"},{"issue":"12","key":"zoi260692r27","first-page":"DS99","article-title":"Economic evaluation of pharmaceuticals. Frankenstein\u2019s monster or vampire of trials?","volume":"34","author":"O\u2019Brien","year":"1996","journal-title":"Med Care"},{"issue":"22","key":"zoi260692r28","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1056\/NEJMe1305534","article-title":"Oxygen-saturation targets in preterm infants.","volume":"368","author":"Polin","year":"2013","journal-title":"N Engl J Med"},{"key":"zoi260692r22","volume-title":"Measuring and Valuing Health for Children: A Review of the Evidence","author":"Xie","year":"2024"},{"key":"zoi260692r9","unstructured":"About natality, 2016-2024 expanded. Centers for Disease Control and Prevention. Accessed May 20, 2025. https:\/\/wonder.cdc.gov\/natality-expanded-current.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2851861\/king_2026_oi_260692_1784056151.82483.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:00:36Z","timestamp":1784646036000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2851861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.24727","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}